Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ruxolitinib, a janus kinase (JAK)-1 and-2 inhibitor modulates microrna (miR) levels in patients with myelofibrosis (MF): miR levels might predict MF treatment outcome
    Meeting Abstract

    Manshouri, T.; Estrov, Z.; Knez, L.; Zhang, Y.; Levine, R. L.; Kantarjian, H. M.; Verstovsek, S.
    Blood (2011)

    Fulltext@MSK | Save
  • A decision analysis of reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for older patients with de-novo myelodysplastic syndrome (MDS): Early transplantation offers survival benefit in higher-risk MDS
    Meeting Abstract

    Koreth, J.; Pidala, J.; PeĢrez, W. S.; Deeg, H. J.; Garcia-Manero, G.; Malcovati, L.; Cazzola, M.; Park, S.; Itzykson, R.; Ades, L.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Inhibition of AKT signaling potently inhibits the growth of JAK and MPL-mutant cells in the myeloproliferative neoplasms in vitro and in vivo
    Meeting Abstract

    Khan, I.; Huang, Z.; Wen, Q. J.; Koppikar, P.; Levine, R. L.; Tefferi, A.; Crispino, J.
    Blood (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Elevated mitochondrial membrane potential in CLL cells is associated with a more aggressive natural history
    Meeting Abstract

    Gardner, J. R.; Knapp, K.; Frattini, M. G.; Lamanna, N.; Brentjens, R.; Jurcic, J. G.; Maslak, P. G.; Berman, E.; Weiss, M.; Scheinberg, D. A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Final report of a phase II study of 5-azacitidine and vorinostat in patients (pts) with newly diagnosed myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) not eligible for clinical trials because poor performance and presence of other comorbidities
    Meeting Abstract

    Garcia-Manero, G.; Estey, E. H.; Jabbour, E.; Borthakur, G.; Kadia, T.; Naqvi, K.; Levine, R. L.; Estrov, Z.; Quintas-Cardama, A.; Konopleva, M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • The impact of obesity on the presentation & outcome of adult acute myeloid leukemia (AML) - ECOG studies E1900 & E3999
    Meeting Abstract

    Foran, J. M.; Sun, Z. X.; Fernandez, H. F.; Cripe, L. D.; Ketterling, R. P.; Racevskis, J.; Luger, S. M.; Paietta, E.; Lazarus, H. M.; Litzow, M. R.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes that target the Down syndrome critical region on chromosome 21
    Meeting Abstract

    Figueroa, M. E.; Malinge, S.; Chlon, T. M.; Li, Y. S.; Paietta, E.; Fernandez, H. F.; Tallman, M. S.; Weiss, M. J.; Chou, S. T.; Melnick, A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Young adults presenting with extramedullary acute myeloid leukemia have a unique sensitivity to high doses of anthracyclines: Subset analysis of ECOG 1900
    Meeting Abstract

    Fernandez, H. F.; Sun, Z. X.; Litzow, M. R.; Luger, S. M.; Paietta, E.; Racevskis, J.; Dewald, G. W.; Ketterling, R. P.; Bennett, J. M.; Rowe, J. M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Late relapses following all-trans retinoic acid for acute promyelocytic leukemia are uncommon, respond well to salvage therapy and occur independently of prognostic factors at diagnosis: Long-term follow-up of North American intergroup study I0129
    Meeting Abstract

    Douer, D.; Zickl, L.; Schiffer, C. A.; Appelbaum, F. R.; Feusner, J. H.; Shepherd, L. E.; Willman, C. L.; Bloomfield, C. D.; Rowe, J. M.; Wiernik, P. H.; more...
    Blood (2011)

    Fulltext@MSK | Save